135 related articles for article (PubMed ID: 38561797)
1. Label-free in vitro assays predict the potency of anti-disialoganglioside chimeric antigen receptor T-cell products.
Logun M; Colonna MB; Mueller KP; Ventarapragada D; Rodier R; Tondepu C; Piscopo NJ; Das A; Chvatal S; Hayes HB; Capitini CM; Brat DJ; Kotanchek T; Edison AS; Saha K; Karumbaiah L
Cytotherapy; 2023 Jun; 25(6):670-682. PubMed ID: 36849306
[TBL] [Abstract][Full Text] [Related]
2. A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives.
Montoya M; Gallus M; Phyu S; Haegelin J; de Groot J; Okada H
Cells; 2024 Apr; 13(9):. PubMed ID: 38727262
[TBL] [Abstract][Full Text] [Related]
3. B7-H3-Targeting Chimeric Antigen Receptors Epstein-Barr Virus-specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3-positive Solid Tumors.
Yeo SP; Kua L; Tan JW; Lim JK; Wong FH; Santos MD; Poh CM; Goh AX; Koh XY; Zhou X; Rajarethinam R; Chen Q; Her Z; Horak ID; Low L; Tan KW
Cancer Res Commun; 2024 Jun; 4(6):1410-1429. PubMed ID: 38717140
[TBL] [Abstract][Full Text] [Related]
4. Chimeric Antigen Receptor T Cell with an Inducible Caspase 9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting.
Ventin M; Cattaneo G; Arya S; Jia J; Gelmi MC; Sun Y; Maggs L; Ksander BR; Verdijk RM; Boland GM; Jenkins RW; Haq R; Jager MJ; Wang X; Ryeom S; Ferrone CR
Clin Cancer Res; 2024 May; ():. PubMed ID: 38767611
[TBL] [Abstract][Full Text] [Related]
5. Multimodal In Vivo Tracking of Chimeric Antigen Receptor T Cells in Preclinical Glioblastoma Models.
Wu WE; Chang E; Jin L; Liu S; Huang CH; Kamal R; Liang T; Aissaoui NM; Theruvath AJ; Pisani L; Moseley M; Stoyanova T; Paulmurugan R; Huang J; Mitchell DA; Daldrup-Link HE
Invest Radiol; 2023 Jun; 58(6):388-395. PubMed ID: 36729074
[TBL] [Abstract][Full Text] [Related]
6. State of the art and perspectives of chimeric antigen receptor T cells cell therapy for neuroblastoma.
Lutskovich D; Meleshko A; Katsin M
Cytotherapy; 2024 May; ():. PubMed ID: 38852096
[TBL] [Abstract][Full Text] [Related]
7. CRISPRi screen of long non-coding RNAs identifies LINC03045 regulating glioblastoma invasion.
Tsung K; Liu KQ; Han JS; Deshpande K; Doan T; Loh YE; Ding L; Yang W; Neman J; Dou Y; Attenello FJ
PLoS Genet; 2024 Jun; 20(6):e1011314. PubMed ID: 38857306
[TBL] [Abstract][Full Text] [Related]
8. Photothermal Prussian blue nanoparticles generate potent multi-targeted tumor-specific T cells as an adoptive cell therapy.
Sweeney EE; Sekhri P; Muniraj N; Chen J; Feng S; Terao J; Chin SJ; Schmidt DE; Bollard CM; Cruz CRY; Fernandes R
Bioeng Transl Med; 2024 May; 9(3):e10639. PubMed ID: 38818122
[TBL] [Abstract][Full Text] [Related]
9. Intracranial CAR-T cell delivery in glioblastoma patients.
Vaughn-Beaucaire P; Choi MJ; Liang O; Lawler SE
Trends Cancer; 2024 May; ():. PubMed ID: 38777680
[TBL] [Abstract][Full Text] [Related]
10. Effect of CRISPR/Cas9-Mediated PD-1-Disrupted Primary Human Third-Generation CAR-T Cells Targeting EGFRvIII on In Vitro Human Glioblastoma Cell Growth.
Nakazawa T; Natsume A; Nishimura F; Morimoto T; Matsuda R; Nakamura M; Yamada S; Nakagawa I; Motoyama Y; Park YS; Tsujimura T; Wakabayashi T; Nakase H
Cells; 2020 Apr; 9(4):. PubMed ID: 32316275
[TBL] [Abstract][Full Text] [Related]
11. Prospective approaches to enhancing CAR T cell therapy for glioblastoma.
Choi SI; Yin J
Front Immunol; 2022; 13():1008751. PubMed ID: 36275671
[TBL] [Abstract][Full Text] [Related]
12. Identification of genetic modifiers enhancing B7-H3-targeting CAR T cell therapy against glioblastoma through large-scale CRISPRi screening.
Li X; Sun S; Zhang W; Liang Z; Fang Y; Sun T; Wan Y; Ma X; Zhang S; Xu Y; Tian R
J Exp Clin Cancer Res; 2024 Apr; 43(1):95. PubMed ID: 38561797
[TBL] [Abstract][Full Text] [Related]
13. B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres.
Nehama D; Di Ianni N; Musio S; Du H; Patané M; Pollo B; Finocchiaro G; Park JJH; Dunn DE; Edwards DS; Damrauer JS; Hudson H; Floyd SR; Ferrone S; Savoldo B; Pellegatta S; Dotti G
EBioMedicine; 2019 Sep; 47():33-43. PubMed ID: 31466914
[TBL] [Abstract][Full Text] [Related]
14. CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies.
Wang D; Prager BC; Gimple RC; Aguilar B; Alizadeh D; Tang H; Lv D; Starr R; Brito A; Wu Q; Kim LJY; Qiu Z; Lin P; Lorenzini MH; Badie B; Forman SJ; Xie Q; Brown CE; Rich JN
Cancer Discov; 2021 May; 11(5):1192-1211. PubMed ID: 33328215
[TBL] [Abstract][Full Text] [Related]
15. Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme.
Marei HE; Althani A; Afifi N; Hasan A; Caceci T; Pozzoli G; Cenciarelli C
Cancer Med; 2021 Aug; 10(15):5019-5030. PubMed ID: 34145792
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
